Описание деятельности
Illumina is improving human health by unlocking the power of the genome. The company's focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina's products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Правление & Наблюдательный совет
| Исполнительный директор |
| Charles Dadswell |
| Правление |
| Ankur Dhingra, Steve Barnard, Nicole Berry, Aimee Hoyt, Kevin Pegels, Li Qing, Kathryne Reeves, Carissa Rollins, Salli Schwartz, Susan Tousi, Bas Verhoef, Gretchen Weightman |
| Наблюдательный совет |
| Stephen P. MacMillan, Frances Arnold, PhD, Caroline Dorsa, Robert S. Epstein, Scott Gottlieb, Gary S. Guthart, Philip Schiller, Sue Siegel, Andrew Teno, Scott B. Ullem |
Данные компании
| Имя: |
Illumina Inc. |
| Адрес: |
5200 Illumina Way,San Diego, California 92122, USA |
| Телефон: |
+1-858-202-4500 |
| Факс: |
+1-858-202-4766 |
| E-mail: |
info@illumina.com
|
| Интернет: |
www.illumina.com/ |
| Индустрия: |
Healthcare |
| Сектор: |
Medical Products |
| Подсектор: |
Advanced Medical Devices |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
48.29% |
| Дата IPO: |
28.07.2000 |
Связи с инвесторами
| Имя: |
- |
| IR телефон: |
+1-858-291-6421 |
| IR-факс: |
- |
| IR e-mail: |
ir@illumina.com
|
